BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16336581)

  • 1. Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease.
    Fortuño A; Beloqui O; San José G; Moreno MU; Zalba G; Díez J
    Kidney Int Suppl; 2005 Dec; (99):S71-5. PubMed ID: 16336581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease.
    Zalba G; Beloqui O; San José G; Moreno MU; Fortuño A; Díez J
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1452-7. PubMed ID: 15860744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis.
    Zalba G; Fortuño A; Orbe J; San José G; Moreno MU; Belzunce M; Rodríguez JA; Beloqui O; Páramo JA; Díez J
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):587-93. PubMed ID: 17194891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension.
    Fortuño A; Oliván S; Beloqui O; San José G; Moreno MU; Díez J; Zalba G
    J Hypertens; 2004 Nov; 22(11):2169-75. PubMed ID: 15480102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocytes of patients wiht systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion.
    Sambo P; Jannino L; Candela M; Salvi A; Donini M; Dusi S; Luchetti MM; Gabrielli A
    J Invest Dermatol; 1999 Jan; 112(1):78-84. PubMed ID: 9886268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients.
    Fortuño A; Bidegain J; San José G; Robador PA; Landecho MF; Beloqui O; Díez J; Zalba G
    J Hypertens; 2009 Jul; 27(7):1420-30. PubMed ID: 19357530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension.
    Fortuño A; Bidegain J; Robador PA; Hermida J; López-Sagaseta J; Beloqui O; Díez J; Zalba G
    Hypertension; 2009 Oct; 54(4):744-50. PubMed ID: 19687351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation.
    Jaimes EA; DeMaster EG; Tian RX; Raij L
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1031-6. PubMed ID: 15059808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney.
    Hwang SY; Siow YL; Au-Yeung KK; House J; O K
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F189-98. PubMed ID: 20980407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis.
    Madrigal-Matute J; Fernandez-Garcia CE; Blanco-Colio LM; Burillo E; Fortuño A; Martinez-Pinna R; Llamas-Granda P; Beloqui O; Egido J; Zalba G; Martin-Ventura JL
    Free Radic Biol Med; 2015 Sep; 86():352-61. PubMed ID: 26117319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications.
    Fortuño A; Bidegain J; Baltanás A; Moreno MU; Montero L; Landecho MF; Beloqui O; Díez J; Zalba G
    J Hypertens; 2010 Sep; 28(9):1944-50. PubMed ID: 20577124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms regulating superoxide generation in experimental models of phenylketonuria: an essential role of NADPH oxidase.
    Lu L; Gu X; Li D; Liang L; Zhao Z; Gao J
    Mol Genet Metab; 2011 Nov; 104(3):241-8. PubMed ID: 21640623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.
    Maly FE; Cross AR; Jones OT; Wolf-Vorbeck G; Walker C; Dahinden CA; De Weck AL
    J Immunol; 1988 Apr; 140(7):2334-9. PubMed ID: 2832475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased phagocytic NADPH oxidase activity associates with coronary artery calcification in asymptomatic men.
    Beloqui O; Moreno MU; San José G; Pejenaute Á; Cortés A; Landecho MF; Díez J; Fortuño A; Zalba G
    Free Radic Res; 2017 Apr; 51(4):389-396. PubMed ID: 28427294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurine chloramine inhibits PMA-stimulated superoxide production in human neutrophils perhaps by inhibiting phosphorylation and translocation of p47(phox).
    Choi HS; Cha YN; Kim C
    Int Immunopharmacol; 2006 Sep; 6(9):1431-40. PubMed ID: 16846837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta.
    Loomis ED; Sullivan JC; Osmond DA; Pollock DM; Pollock JS
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1058-64. PubMed ID: 16144972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells.
    Vejrazka M; Mícek R; Stípek S
    Biochim Biophys Acta; 2005 Mar; 1722(2):143-7. PubMed ID: 15716123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome.
    Fortuño A; San José G; Moreno MU; Beloqui O; Díez J; Zalba G
    Diabetes; 2006 Jan; 55(1):209-15. PubMed ID: 16380495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits.
    Chan EC; Datla SR; Dilley R; Hickey H; Drummond GR; Dusting GJ
    Cardiovasc Res; 2007 Sep; 75(4):710-8. PubMed ID: 17659266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of monocytes by interferon-gamma has no effect on the level or affinity of the nicotinamide adenine dinucleotide-phosphate oxidase and on agonist-dependent superoxide formation.
    Thelen M; Wolf M; Baggiolini M
    J Clin Invest; 1988 Jun; 81(6):1889-95. PubMed ID: 2838524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.